NMRA icon

Neumora Therapeutics

88 hedge funds and large institutions have $725M invested in Neumora Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

more ownership

Funds ownership:

3% less capital invested

Capital invested by funds: $745M → $725M (-$20M)

6% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 18

83% less call options, than puts

Call options by funds: $75K | Put options by funds: $453K

Holders
88
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$75K
Puts
$453K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$3.42M
27
$2.82M
28
$2.58M
29
$2.24M
30
$2.06M
31
$1.91M
32
$1.88M
33
$1.88M
34
$1.71M
35
$1.67M
36
$1.52M
37
$1.51M
38
$1.48M
39
$1.44M
40
$1.35M
41
$1.26M
42
$1.14M
43
$941K
44
$907K
45
$899K
46
$871K
47
$857K
48
$755K
49
$698K
50
$564K